Arndt Vogel, Head of the Center for Personalized Medicine, MHH at Medical University of Hanover, shared a post on X about a paper by Jun Fang et al. published in Hepatology:
“Identifying irAEs could serve as a potential biomarker may enhance patient selection and risk stratification before LT.”
Title: Immune-related adverse events are a potent predictor of post-transplant rejection in HCC: a multicentre retrospective cohort study
Authors: Jun Fang, Siyi Zhong, Tielong Wang, Kang He, Aibo Mu, Meiching Ong, Yimou Lin, Zebin Zhu, Ning Wang, Jiancheng Wu, Zhihao Wang, Zhao Li, Feng Gao, Li Zhuang, Zhiyong Guo, Shusen Zheng, Hao Li, Shugeng Zhang, Qi Ling
Read the Full Article.
Other articles featuring Arndt Vogel on OncoDaily.